Jury Reaches Defense Verdict for J&J at Conclusion of Bifurcated Talcum Powder Trial



DOCUMENTS
  • Verdict Sheet


PHILADELPHIA –– Jurors have reached a defense verdict in favor of Johnson & Johnson and Johnson & Johnson Consumer Inc. at the conclusion of a bifurcated talcum powder trial, rejecting the plaintiff’s claims that she developed ovarian cancer as a result of using the defendants’ talcum powder products.

The Pennsylvania Court of Common Pleas for Philadelphia County jury reached the verdict just moments ago, completing a trial that kicked off on Aug. 18.

According to the verdict sheet, jurors found that the plaintiffs had not proven by a preponderance of the evidence that Johnson & Johnson’s Baby Powder was a …






UPCOMING CONFERENCES




HarrisMartin’s Webinar Series: MDL Update on Philips CPAP, BiPAP & Ventilator Litigation

October 21, 2021 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS



HarrisMartin's New Jersey Asbestos Litigation Conference

February 09, 2022 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS